First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued (TRAXV) — Strategic Asset Allocation Index
First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued (TRAXV) has a Strategic Asset Allocation Index of 9.1% as of December 2024. Strategic assets (PP&E of $- plus long-term investments of $35.47 Million) total $35.47 Million, measured against net assets of $391.60 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See TRAXV net asset quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued Strategic Asset Allocation Index (2023–2024)
This chart shows how First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued's Strategic Asset Allocation Index has evolved across 2 annual periods from 2023 to 2024. As of December 2024, the index stands at 9.1%, representing strategic assets of $35.47 Million against net assets of $391.60 Million USD. For live market cap and overall valuation, see market cap of First Tracks Biotherapeutics, Inc. Ordin.
Annual Strategic Asset Allocation Index for First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued (2023–2024)
The table below presents the year-by-year Strategic Asset Allocation Index for First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued from 2023 to 2024, covering 2 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See TRAXV net asset value for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 9.1% | $35.47 Million | $- | $35.47 Million | $391.60 Million | ▲ +2.5 pp |
| 2023 | 6.6% | $27.03 Million | $- | $27.03 Million | $409.85 Million | — |